In-Hospital Mortality Evaluated for SARS-CoV-2-Linked Sepsis
Medically reviewed by Drugs.com.
By Elana Gotkine HealthDay Reporter
WEDNESDAY, Oct. 4, 2023 -- From March 2020 to November 2022, there was a decline in crude in-hospital mortality for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-associated sepsis, according to a study published online Sept. 29 in JAMA Network Open.
Claire N. Shappell, M.D., M.P.H., from Harvard Medical School/Harvard Pilgrim Health Care Institute in Boston, and colleagues conducted a retrospective cohort study of adults hospitalized at five Massachusetts hospitals between March 2020 and November 2022 to describe trends in the quarterly incidence and in-hospital mortality for SARS-CoV-2-associated and presumed bacterial sepsis.
Data were included for 431,017 hospital encounters from 261,595 individuals. Of these, 5.4 percent were from SARS-CoV-2, 1.5 percent had SARS-CoV-2-associated sepsis, and 7.1 percent had presumed bacterial sepsis without SARS-CoV-2 infection. The researchers found a decline in the crude in-hospital mortality for SARS-CoV-2-associated sepsis from 33.4 to 14.9 percent in the first and last quarter (adjusted odds ratio, 0.88 per quarter). For presumed bacterial sepsis, crude mortality was 14.5 percent and was stable across quarters. Electronic health record (EHR)-based SARS-CoV-2-associated sepsis criteria performed well relative to sepsis-3 criteria on medical record reviews of 200 SARS-CoV-2-positive hospitalizations (sensitivity, 90.6 percent; specificity, 91.2 percent).
"These findings highlight the high burden of SARS-CoV-2-associated sepsis and demonstrate the feasibility of using EHR-based algorithms to conduct surveillance for viral sepsis," the authors write.
One author disclosed ties to UpToDate and Cytovale.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
![](/img/logo/vendor/healthday-logo.png)
© 2024 HealthDay. All rights reserved.
Posted October 2023
Further Support and Information on COVID-19
Read this next
Prolonged β-Lactam Antibiotic Infusions Aid Sepsis, Septic Shock Outcomes
FRIDAY, June 14, 2024 -- Among adults in the intensive care unit with sepsis or septic shock, the use of prolonged β-lactam antibiotic infusions is associated with lower risk...
Residual Risk Seen for Death, Postacute Sequelae in Third Year After COVID-19 Hospitalization
THURSDAY, June 13, 2024 -- For individuals with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, the risks for death and postacute sequelae of COVID-19...
Systemic Side Effects of COVID-19 Vaccine Tied to Greater nAB Response
TUESDAY, June 11, 2024 -- Short-term systemic side effects of the severe acute respiratory coronavirus 2 (SARS-CoV-2) mRNA vaccine are associated with greater long-lasting...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.